Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Reply to thread

Message

I cannot believe that ALK is moving forward with Grastek and Ragwitek. After analysts estimated grass tablets at a billion dollar industry and a billion investment, Grastek and Greer's Oralair are struggling to hit $10 million in sales. And ALK thinks they're better than Merck with their 20 know-nothing fluff reps with clueless sales leadership? Who makes these decisions?

[QUOTE="anonymous, post: 5826592"] I cannot believe that ALK is moving forward with Grastek and Ragwitek. After analysts estimated grass tablets at a billion dollar industry and a billion investment, Grastek and Greer's Oralair are struggling to hit $10 million in sales. And ALK thinks they're better than Merck with their 20 know-nothing fluff reps with clueless sales leadership? Who makes these decisions? [/QUOTE]

Name

Verification